• Study on the Safety and Effectiveness of Apixaban, Edoxaban, and Phenprocoumon for Patients with Chronic Thromboembolic Pulmonary Hypertension Undergoing Balloon Pulmonary Angioplasty

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    The Netherlands
  • Study on Dacarbazine, Pembrolizumab, Nivolumab, and Ipilimumab for Patients with Unresectable or Metastatic Melanoma Resistant to Immunotherapy

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Germany
  • Study of catequentinib (AL3818) combined with platinum chemotherapy for patients with recurrent or metastatic ovarian, fallopian tube, or primary peritoneal cancer

    Not recruiting

    3 1 1
    Italy Spain
  • Study of Monalizumab and Volrustomig for Patients with MSI and/or dMMR Metastatic Cancer

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    France
  • Study of Trifluridine and Tipiracil in Patients with ER-Positive, HER2-Negative Advanced Breast Cancer After Chemotherapy

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    The Netherlands
  • Study on the Effectiveness of Aprepitant and Fosaprepitant in Preventing Nausea and Vomiting in Children Undergoing Chemotherapy

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands
  • Study on the Effects of Hyperbaric Oxygen Therapy for Patients with Moderate-to-Severe Ulcerative Colitis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands
  • Study on Sentinel Lymph Node Mapping Using Gallium-68 Chloride and Tilmanocept in Patients with High-Risk Endometrial Cancer

    Not recruiting

    3 1 1 1
    The Netherlands
  • Study on the Safety and Effectiveness of Melatonin and Ocrelizumab for Patients with Primary Progressive Multiple Sclerosis

    Not recruiting

    2 1 1
    Spain
  • Study of L19IL2 and L19TNF for Patients with Advanced Basal Cell Carcinoma or Cutaneous Squamous Cell Carcinoma Not Eligible for Surgery or Radiation

    Not recruiting

    2 1 1
    Germany Poland

powered by